MET5 20 mg is a synthetic enkephalin analog, a pentapeptide designed to interact with opioid receptors for pain modulation research. Available in a vial from Generic Peptides, it is used in experimental settings to study analgesia and opioid pathways, requiring reconstitution before use.
MET5 20 mg works by binding to delta-opioid receptors, mimicking natural enkephalins to modulate pain signals and stress responses in the central nervous system. In research, it helps explore analgesic mechanisms, with effects beginning within minutes and lasting hours in models.
Side effects of MET5 20 mg in research may include respiratory depression, tolerance development, or nausea in models. Human safety data is limited, so it is strictly for laboratory use. Monitor for adverse reactions in experiments and consult protocols for risk management.
MET5 20 mg is not established as safe for human use and is intended solely for research purposes. Potential risks in experimental settings include opioid-related effects like dependence or sedation. Use is limited to controlled lab environments under professional supervision.
MET5 20 mg has a half-life of approximately 1-2 hours in experimental models, requiring frequent dosing for sustained effects. It remains detectable for about 12-24 hours, depending on dosage, metabolism, and testing methods. Researchers should use appropriate assays for clearance.
MET5 binds to delta-opioid receptors, inhibiting pain transmission and modulating stress responses. It mimics enkephalins, offering a targeted approach in opioid research. Effects begin rapidly and are short-lived. What doesn't happen: no broad systemic impact, but monitoring is essential.
MET5 20 mg excels for researchers exploring pain and opioid pathways, requiring controlled lab conditions to maximize its experimental potential.
Best for researchers in neuroscience or pharmacology; intended for laboratory use only, not for human consumption. Not recommended for personal use or those without research credentials.
| Substance | Enkephalin |
|---|---|
| Concentration | 20 mg |
| Form | Vial (requires reconstitution) |
| Pack Size | Vial |
| Half-life | ~1-2 hours |
| Aromatization/Hepatic | Non-applicable / Minimal hepatic |
| Primary Use | Opioid and pain research |
| Manufacturer | Generic Peptides |
| Brand | MET5 |
DSIP: Complements stress studies.
Selank: Enhances anxiety research.
Semax: Supports cognitive opioid interactions.
Cycle Support: Ensures lab safety protocols.
MET5 20 mg vs DSIP: MET5 targets opioids; DSIP modulates sleep.
MET5 20 mg vs Selank: MET5 focuses on pain; Selank on anxiety.
MET5 20 mg vs Morphine: MET5 is peptide-based; Morphine is a classic opioid.
Consult a research professional to ensure safe handling and monitor experimental outcomes.
What is MET5 20 mg?
MET5 is an enkephalin analog for opioid research; see What is MET5 20 mg. For lab use only—consult professionals.
How does MET5 20 mg work?
It binds to opioid receptors; see How Does MET5 20 mg Work. Research use only—consult professionals.
What are side effects of MET5 20 mg?
Effects include respiratory depression; see What Are Side Effects of MET5 20 mg. Handle with care—consult professionals.
Is MET5 20 mg safe?
Not for human use, for research only; see Is MET5 20 mg Safe. Consult professionals for monitoring.